|
Market Closed -
NYSE
21:00:02 22/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.230 USD | +9.82% |
|
+12.84% | -65.16% |
| 08-14 | ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says | MT |
| 08-13 | ADC Therapeutics SA, Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +9.82% | +12.84% | +27.45% | +12.84% | -65.16% | -64.66% | +70.86% | -95.81% | - | 143M | |
| -0.07% | +5.66% | +3.06% | +63.41% | +85.18% | +54.34% | +113.69% | +10.14% | - | 74.33B | |
| -1.45% | -1.43% | -5.17% | +10.55% | +19.34% | +36.82% | +80.62% | +218.82% | +5,509.18% | 62.26B | |
| -0.66% | +7.14% | +3.24% | +70.83% | +67.46% | +39.36% | +29.20% | -56.67% | - | 27.72B | |
| -0.15% | +0.75% | -2.55% | +22.53% | -30.58% | -16.69% | +361.67% | +353.02% | +705.47% | 26.42B | |
| +2.93% | +4.32% | -10.59% | +11.84% | +5.96% | +2.18% | -3.60% | -70.27% | - | 24.62B | |
| +0.84% | +7.70% | +5.95% | +39.26% | +12.43% | +26.09% | -10.70% | -19.07% | +97.83% | 20.72B | |
| +0.87% | -2.52% | -17.14% | +21.39% | +173.78% | +151.81% | +328.17% | +1,384.37% | +645.67% | 15.01B | |
| +1.63% | +2.20% | +6.60% | +13.24% | +32.67% | +46.92% | +170.72% | +187.87% | +294.50% | 14.18B | |
| +1.30% | -1.61% | +34.49% | +19.89% | -2.12% | -10.37% | +815.51% | +230.50% | +99.07% | 13.48B | |
| -1.09% | +1.87% | -8.88% | +17.89% | +24.99% | -3.79% | +513.52% | - | - | 15.1B | |
| -0.60% | -0.85% | +1.34% | +1.16% | -10.91% | +17.90% | +238.35% | +559.67% | +4,388.15% | 12.06B | |
| -3.42% | +0.21% | +6.26% | +9.54% | -15.13% | -26.06% | +162.74% | +129.43% | - | 11.66B | |
| +0.04% | -2.48% | -12.32% | -14.63% | +6.37% | +40.08% | +118.38% | +99.73% | +665.46% | 9.39B | |
| +4.46% | +1.68% | -17.15% | -12.37% | +8.24% | +124.21% | +163.80% | +14.52% | +888.45% | 9.72B | |
| +9.94% | +14.13% | +22.56% | +28.67% | +369.19% | +247.94% | +463.03% | -8.20% | - | 8.96B | |
| +0.17% | -0.32% | -4.61% | +13.26% | +27.92% | +76.34% | +12.53% | +126.83% | - | 8.77B | |
| -1.12% | +4.41% | +0.57% | +15.84% | +10.21% | -23.63% | +106.91% | -22.66% | - | 8.73B | |
| -0.07% | +1.12% | -13.76% | -8.32% | +180.74% | +501.50% | +675.46% | -51.79% | -42.70% | 8.11B | |
| +1.12% | +3.49% | +10.37% | +19.23% | +9.62% | +145.97% | +456.67% | - | - | 6.98B | |
| Average | +1.16% | -0.17% | +1.49% | +17.80% | +45.51% | +68.31% | +243.38% | +166.14% | +1,325.11% | 18.92B | |
| Weighted average by Cap. | +0.22% | +1.29% | -0.27% | +27.83% | +46.04% | +51.75% | +187.56% | +158.03% | +2,332.42% |
- Stock Market
- Stocks
- ADCT Stock
- Sector ADC Therapeutics SA
Select your edition
All financial news and data tailored to specific country editions
